Definitive Contract 75N93021C00034
Award Date
8/16/21
Potential Completion Date
9/16/24
Potential Value
$1.8M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Intralytix Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21046, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This is a $240,000.00 firm fixed price contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Intralytix Inc., a for-profit biotech organization that specializes in bacteriophage-based products for food safety and public health applications. The contract, which does not have a set-aside designation, is for the "Elucidation of Interaction of Bacteriophages with Bacteria in Various Food Matrixes, and the Impact on the Food...
This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and other...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price Definitive Contract to Adaptive Phage Therapeutics, Inc. to develop a rapid and scalable method for bacteriophage manufacture and purification under the Small Business Innovation Research (SBIR) Phase I program. The contract has a potential value of $296,787.00 and a completion date of August 15, 2022. This contract is not set...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $1,799,353.00 Small Business Innovation Research (SBIR) Program Phase I contract to Redbud Labs, Inc., a for-profit microfluidic chip manufacturer. The contract is a firm fixed price definitive contract to implement extraction compatibility with whole blood and tissue lysates, producing a portable and rapidly installable instrument that meets industry...
This is a $299,408 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Darwin Biosciences, Inc., a woman-owned small business. The contract is for the development of rapid diagnostic assays for self-monitoring of acute or rebound HIV-1 infection. As a Small Business Innovation Research (SBIR) award, this contract is set aside for small businesses. The contract has a firm fixed price structure and a period of performance...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Tolka.ai Inc. (doing business as Tolka AI Therapeutics), a for-profit small business. The contract, valued at $299,993.00, is for research and development efforts related to NIAID's mission needs and SBIR program objectives. The original solicitation included a variety of research topics,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The $548,977.00 cost-plus-fixed-fee contract is for the delivery of services in support of NIAID's infectious disease research and product development initiatives. This award is a task order under an existing Indefinite...